All stock lists
Connect Biopharma Holdings Ltd (CNTB)
NASDAQ: CNTB · Real-Time Price · USD
Healthcare · Biotechnology
0.85+0.08 (+10.39%)
Insider Score
––Not scored
CNTB Insider Score
Insiders here have filed 2 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
CNTB analyst forecast
CNTB analyst consensus
Moderate Buy4 ratings
Buy 4 Hold 0 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
CNTB 12-month price target
No published price targets in the last 12 months.
Best analysts covering CNTB
- HC Wainwright & Co.67%success rate · 6 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
CNTB analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2026-10-08 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2026-10-02 |
| — | BTIG | Buy | — | — | Reiterated | 2026-09-30 |
| — | Oppenheimer | Outperform | — | — | Reiterated | 2026-09-22 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2026-09-17 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2026-09-16 |
| — | BTIG | Buy | — | — | Reiterated | 2026-09-15 |
| — | Piper Sandler | Overweight | — | — | Upgraded | 2026-06-26 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2026-06-25 |
| — | BTIG | Buy | — | — | Reiterated | 2026-04-01 |
| — | BTIG | Buy | — | — | Reiterated | 2026-03-31 |
| — | BTIG | Buy | — | — | Reiterated | 2025-11-13 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2025-08-13 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2025-04-01 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2025-03-31 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-09-06 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-06-13 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-04-17 |
| — | Cantor Fitzgerald | Overweight | — | — | Reiterated | 2023-09-13 |
| — | SVB Leerink | Outperform | — | — | Reiterated | 2023-02-08 |
| — | Piper Sandler | Neutral | — | — | Downgraded | 2022-05-05 |
| — | SVB Leerink | Outperform | — | — | Reiterated | 2022-05-04 |
| — | SVB Leerink | Outperform | — | — | Reiterated | 2022-01-06 |
CNTB earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-03-31 | -0.30 | -0.27 | $538 | $0 |
| 2026-05-12 | -0.29 | -0.34 | $743K | $24K |
| 2026-08-12 | -0.31 | -0.27 | $743K | $2.7M |
| 2026-11-11 | -0.27 | 0.00 | $115K | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.